Finance

Lists
Why is MEOBF up 10,07%?
Dive Deeper
MEOBF:OTCMKTS
Mesoblast Ltd
1,53 US$
+10,07%
(+0,14) 1D
9 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MEOBF...
Open
1,53 US$
High
1,53 US$
Low
1,53 US$
Mkt. cap
1,82 მლრდ.
Avg. vol.
387,00
Volume
0,00
52-wk high
2,59 US$
52-wk low
1,14 US$
Beta
1,68
Shares outstanding
1,30 მლრდ.
No. of employees
108
Open
1,53 US$
High
1,53 US$
Low
1,53 US$
Mkt. cap
1,82 მლრდ.
Avg. vol.
387,00
Volume
0,00
52-wk high
2,59 US$
52-wk low
1,14 US$
Beta
1,68
Shares outstanding
1,30 მლრდ.
No. of employees
108
News stories
From web sources and news partners
Profile
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
About Mesoblast Ltd
CEOსილვიუ იტესკუ
Employees108
Founded2004
Headquarters-
Sector-
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
25,67 მლნ.
25,67 მლნ.
34,45 მლნ.
34,45 მლნ.
Cost of goods sold
26,88 მლნ.
26,88 მლნ.
-14,87 მლნ.
-14,87 მლნ.
Cost of revenue
26,88 მლნ.
26,88 მლნ.
-14,87 მლნ.
-14,87 მლნ.
Research and development expenses
-
-
45,07 მლნ.
45,07 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14,27 მლნ.
14,27 მლნ.
14,40 მლნ.
14,40 მლნ.
Operating expense
12,95 მლნ.
12,95 მლნ.
60,79 მლნ.
60,79 მლნ.
Total operating expenses
39,83 მლნ.
39,83 მლნ.
45,92 მლნ.
45,92 მლნ.
Operating income
-14,16 მლნ.
-14,16 მლნ.
-11,47 მლნ.
-11,47 მლნ.
Other non operating income
-4,16 მლნ.
-4,16 მლნ.
2,61 მლნ.
2,61 მლნ.
EBT including unusual items
-19,86 მლნ.
-19,86 მლნ.
-8,58 მლნ.
-8,58 მლნ.
EBT excluding unusual items
-23,68 მლნ.
-23,68 მლნ.
-10,94 მლნ.
-10,94 მლნ.
Income tax expense
222,50 ათ.
222,50 ათ.
84,00 ათ.
84,00 ათ.
Effective tax rate
-1,12%
-1,12%
-0,98%
-0,98%
Other operating expenses
-1,32 მლნ.
-1,32 მლნ.
1,31 მლნ.
1,31 მლნ.
Net income
-20,08 მლნ.
-20,08 მლნ.
-8,67 მლნ.
-8,67 მლნ.
Net profit margin
-78,22%
-78,22%
-25,16%
-25,16%
Earnings per share
-
-
-
-
Interest and investment income
-
-
1,96 მლნ.
1,96 მლნ.
Interest expense
-5,64 მლნ.
-5,64 მლნ.
-4,29 მლნ.
-4,29 მლნ.
Net interest expenses
-5,64 მლნ.
-5,64 მლნ.
-2,34 მლნ.
-2,34 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-12,53 მლნ.
-12,53 მლნ.
-9,77 მლნ.
-9,77 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები